Melisana: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
What changed
Melisana
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€2.0m
2024 · €2.6m-€624,648
Equity
€11.4m
2024 · €9.4m+€2.0m
Cash
€2.8m
2024 · €4.9m-€2.1m
Balance sheet total
€15.4m
2024 · €17.6m-€2.2m
Largest movements
Assets
- Current investments -€3.0m
no longer reported in 2025 (was €3.0m)
- Cash -€2.1m
down €2.1m (-42.6%), from €4.9m to €2.8m
mainly Other debts (-€4.1m) and Stocks and contracts (-€1.5m)
- Stocks and contracts +€1.5m
up €1.5m (+30.3%), from €5.1m to €6.6m
- Intangible fixed assets +€1.2m
up €1.2m (+1,354%), from €88,283 to €1.3m
- Receivables within one year +€418,136
up €418,136 (+37.2%), from €1.1m to €1.5m
of which Trade receivables: +€395,271
Equity and liabilities
- Other debts -€4.1m
no longer reported in 2025 (was €4.1m)
- Profit (loss) carried forward +€2.0m
up €2.0m (+24.0%), from €8.3m to €10.3m
Income statement
- Turnover +€1.4m
up €1.4m (+5.0%), from €28.0m to €29.4m
- Goods and materials +€1.1m
up €1.1m (+9.7%), from €11.4m to €12.5m
of which Purchases: +€3.2m
- Services and other goods +€633,328
up €633,328 (+7.5%), from €8.4m to €9.1m
- Staff costs +€375,468
up €375,468 (+8.6%), from €4.4m to €4.7m
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Result 2024
€2.6m
Turnover
+€1.4m
Other operating income
-€115
Goods and materials
-€1.1m
Services and other goods
-€633,328
Staff costs
-€375,468
Depreciation
-€186,232
Write-downs
+€180,660
Other operating charges
-€114,165
Other operating items
+€15,000
Financial income
-€11,571
Financial charges
+€15,532
Taxes
+€178,810
Result 2025
€2.0m
raises the resultlowers the resultnot broken down further in the accounts
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
From operations
-€3.6m
Investment
+€1.5m
Financing
€0
Cash 2024
€4.9m
From operations (derived)
-€3.6m
Net result for the year
+€2.0m
Depreciation
+€405,135
Stocks and contracts
-€1.5m
Receivables within one year
-€418,136
Deferred charges and accrued income
+€105,753
Trade debts
-€9,910
Tax, wage and social debts
-€122,220
Other debts
-€4.1m
Accrued charges and deferred income
+€93,500
Investment (derived)
+€1.5m
Investment in fixed assets (net)
-€1.5m
Current investments
+€3.0m
Cash 2025
€2.8m
brings cash intakes cash out
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €17,570,687 | €15,410,204 | -€2.2m | -12.3% |
| Fixed assets | 21/28 | €3,342,264 | €4,414,588 | +€1.1m | +32.1% |
| Intangible fixed assets | 21 | €88,283 | €1,283,499 | +€1.2m | +1,354% |
| Tangible fixed assets | 22/27 | €3,252,510 | €3,129,619 | -€122,891 | -3.8% |
| Land and buildings | 22 | €3,231,505 | €3,099,277 | -€132,228 | -4.1% |
| Furniture and vehicles | 24 | €21,005 | €30,342 | +€9,337 | +44.4% |
| Financial fixed assets | 28 | €1,470 | €1,470 | = | 0.0% |
| Other financial fixed assets | 284/8 | €1,470 | €1,470 | = | 0.0% |
| Amounts receivable and cash guarantees | 285/8 | €1,470 | €1,470 | = | 0.0% |
| Current assets | 29/58 | €14,228,423 | €10,995,616 | -€3.2m | -22.7% |
| Stocks and contracts in progress | 3 | €5,098,999 | €6,642,655 | +€1.5m | +30.3% |
| Stocks | 30/36 | €5,098,999 | €6,642,655 | +€1.5m | +30.3% |
| Goods purchased for resale | 34 | €4,960,132 | €5,964,537 | +€1.0m | +20.2% |
| Advance payments | 36 | €138,866 | €678,117 | +€539,251 | +388% |
| Amounts receivable within one year | 40/41 | €1,124,563 | €1,542,700 | +€418,136 | +37.2% |
| Trade receivables | 40 | €971,472 | €1,366,744 | +€395,271 | +40.7% |
| Other amounts receivable | 41 | €153,091 | €175,956 | +€22,865 | +14.9% |
| Current investments | 50/53 | €3,000,000 | - | -€3.0m | |
| Other investments | 51/53 | €3,000,000 | - | -€3.0m | |
| Cash at bank and in hand | 54/58 | €4,899,108 | €2,810,262 | -€2.1m | -42.6% |
| Deferred charges and accrued income | 490/1 | €105,753 | - | -€105,753 | |
| Total equity and liabilities | 10/49 | €17,570,687 | €15,410,204 | -€2.2m | -12.3% |
| Equity | 10/15 | €9,402,753 | €11,397,027 | +€2.0m | +21.2% |
| Contributions | 10/11 | €1,000,000 | €1,000,000 | = | 0.0% |
| Capital | 10 | €1,000,000 | €1,000,000 | = | 0.0% |
| Issued capital | 100 | €1,000,000 | €1,000,000 | = | 0.0% |
| Reserves | 13 | €107,596 | €107,596 | = | 0.0% |
| Non-distributable reserves | 130/1 | €100,000 | €100,000 | = | 0.0% |
| Legal reserve | 130 | €100,000 | €100,000 | = | 0.0% |
| Tax-exempt reserves | 132 | €7,596 | €7,596 | = | 0.0% |
| Profit (loss) carried forward | 14 | €8,295,157 | €10,289,431 | +€2.0m | +24.0% |
| Amounts payable | 17/49 | €8,167,934 | €4,013,177 | -€4.2m | -50.9% |
| Amounts payable within one year | 42/48 | €8,167,934 | €3,919,677 | -€4.2m | -52.0% |
| Trade debts | 44 | €2,892,571 | €2,882,661 | -€9,910 | -0.3% |
| Suppliers | 440/4 | €2,892,571 | €2,882,661 | -€9,910 | -0.3% |
| Taxes, remuneration and social security | 45 | €1,159,235 | €1,037,016 | -€122,220 | -10.5% |
| Taxes | 450/3 | €206,000 | €18,955 | -€187,045 | -90.8% |
| Remuneration and social security | 454/9 | €953,235 | €1,018,061 | +€64,825 | +6.8% |
| Other amounts payable | 47/48 | €4,116,127 | - | -€4.1m | |
| Accrued charges and deferred income | 492/3 | - | €93,500 | +€93,500 | |
| Operating income | 70/76A | €28,293,551 | €29,702,120 | +€1.4m | +5.0% |
| Turnover | 70 | €28,035,862 | €29,444,546 | +€1.4m | +5.0% |
| Other operating income | 74 | €257,689 | €257,574 | -€115 | 0.0% |
| Operating charges | 60/66A | €24,688,602 | €26,904,590 | +€2.2m | +9.0% |
| Goods for resale, raw materials and consumables | 60 | €11,377,503 | €12,479,957 | +€1.1m | +9.7% |
| Purchases | 600/8 | €10,214,340 | €13,386,559 | +€3.2m | +31.1% |
| Change in stocks: decrease (increase) | 609 | €1,163,164 | -€906,603 | -€2.1m | |
| Services and other goods | 61 | €8,447,347 | €9,080,675 | +€633,328 | +7.5% |
| Remuneration, social security and pensions | 62 | €4,364,836 | €4,740,304 | +€375,468 | +8.6% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €218,903 | €405,135 | +€186,232 | +85.1% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €82,857 | -€97,803 | -€180,660 | |
| Other operating charges | 640/8 | €182,157 | €296,322 | +€114,165 | +62.7% |
| Non-recurring operating charges | 66A | €15,000 | - | -€15,000 | |
| Operating profit (loss) | 9901 | €3,604,949 | €2,797,530 | -€807,419 | -22.4% |
| Financial income | 75/76B | €46,583 | €35,012 | -€11,571 | -24.8% |
| Recurring financial income | 75 | €46,583 | €35,012 | -€11,571 | -24.8% |
| Income from current assets | 751 | €45,903 | €33,523 | -€12,380 | -27.0% |
| Other financial income | 752/9 | €680 | €1,490 | +€809 | +119% |
| Financial charges | 65/66B | €126,610 | €111,078 | -€15,532 | -12.3% |
| Recurring financial charges | 65 | €126,610 | €111,078 | -€15,532 | -12.3% |
| Other financial charges | 652/9 | €126,610 | €111,078 | -€15,532 | -12.3% |
| Profit (loss) for the period before taxes | 9903 | €3,524,922 | €2,721,465 | -€803,457 | -22.8% |
| Income taxes | 67/77 | €906,000 | €727,190 | -€178,810 | -19.7% |
| Taxes | 670/3 | €906,000 | €727,190 | -€178,810 | -19.7% |
| Profit (loss) for the period | 9904 | €2,618,922 | €1,994,274 | -€624,648 | -23.9% |
| Profit (loss) for the period to be appropriated | 9905 | €2,618,922 | €1,994,274 | -€624,648 | -23.9% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 25 October 2026 via checked.be.